$39.83
0.190.48%
Last update: Oct 28, 4:46 PM
LB Pharmaceuticals Inc
LBRXNASDAQ
LB Pharmaceuticals (LBRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.81 | $-0.69 | $-0.37 | $-0.57 |
| Actual | $-1.71 | $-0.67 | $-0.45 | $-0.61 |
| Surprise | -111.1% | +2.90% | -21.6% | -7.02% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.54 | $-1.55 | $-1.57 | $-1.49 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-1.71 | $-0.81 | -111.1 % |
| Q1 | May 12, 2026 | $-0.67 | $-0.69 | 2.90 % |
| Q4 | Mar 26, 2026 | $-0.45 | $-0.37 | -21.6 % |
| Q3 | Nov 6, 2025 | $-0.61 | $-0.57 | -7.02 % |
